Sana Biotechnology Stock Probability of Future Stock Price Finishing Over 14.69

SANA Stock  USD 10.44  0.66  6.75%   
Sana Biotechnology's implied volatility is one of the determining factors in the pricing options written on Sana Biotechnology. Implied volatility approximates the future value of Sana Biotechnology based on the option's current value. Options with high implied volatility have higher premiums and can be used to hedge the downside of investing in Sana Biotechnology over a specific time period. For example, 2024-05-17 CALL at $10.0 is a CALL option contract on Sana Biotechnology's common stock with a strick price of 10.0 expiring on 2024-05-17. The contract was last traded on 2024-05-03 at 14:33:17 for $1.44 and, as of today, has 13 days remaining before the expiration. The option is currently trading at a bid price of $1.5, and an ask price of $1.75. The implied volatility as of the 4th of May is 180.87. View All Sana options

Closest to current price Sana long CALL Option Payoff at Expiration

Sana Biotechnology's future price is the expected price of Sana Biotechnology instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Sana Biotechnology performance during a given time horizon utilizing its historical volatility. Check out Sana Biotechnology Backtesting, Sana Biotechnology Valuation, Sana Biotechnology Correlation, Sana Biotechnology Hype Analysis, Sana Biotechnology Volatility, Sana Biotechnology History as well as Sana Biotechnology Performance.
For information on how to trade Sana Stock refer to our How to Trade Sana Stock guide.
  
At present, Sana Biotechnology's Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 2.90, whereas Price Earnings Ratio is forecasted to decline to (2.94). Please specify Sana Biotechnology's target price for which you would like Sana Biotechnology odds to be computed.

Sana Biotechnology Target Price Odds to finish over 14.69

The tendency of Sana Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over $ 14.69  or more in 90 days
 10.44 90 days 14.69 
near 1
Based on a normal probability distribution, the odds of Sana Biotechnology to move over $ 14.69  or more in 90 days from now is near 1 (This Sana Biotechnology probability density function shows the probability of Sana Stock to fall within a particular range of prices over 90 days) . Probability of Sana Biotechnology price to stay between its current price of $ 10.44  and $ 14.69  at the end of the 90-day period is about 7.85 .
Given the investment horizon of 90 days the stock has the beta coefficient of 4.06 . This usually implies as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Sana Biotechnology will likely underperform. Additionally Sana Biotechnology has an alpha of 0.8541, implying that it can generate a 0.85 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
   Sana Biotechnology Price Density   
       Price  

Predictive Modules for Sana Biotechnology

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Sana Biotechnology. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Sana Biotechnology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
3.729.6615.60
Details
Intrinsic
Valuation
LowRealHigh
3.759.6915.63
Details
Naive
Forecast
LowNextHigh
5.4211.3717.31
Details
7 Analysts
Consensus
LowTargetHigh
9.1010.0011.10
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Sana Biotechnology. Your research has to be compared to or analyzed against Sana Biotechnology's peers to derive any actionable benefits. When done correctly, Sana Biotechnology's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Sana Biotechnology.

Sana Biotechnology Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Sana Biotechnology is not an exception. The market had few large corrections towards the Sana Biotechnology's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Sana Biotechnology, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Sana Biotechnology within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
0.85
β
Beta against NYSE Composite4.06
σ
Overall volatility
1.30
Ir
Information ratio 0.18

Sana Biotechnology Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Sana Biotechnology for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Sana Biotechnology can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Sana Biotechnology is way too risky over 90 days horizon
Sana Biotechnology appears to be risky and price may revert if volatility continues
Net Loss for the year was (283.25 M) with profit before overhead, payroll, taxes, and interest of 0.
Sana Biotechnology currently holds about 484.8 M in cash with (253.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.57.
Sana Biotechnology has a frail financial position based on the latest SEC disclosures
Over 85.0% of the company shares are owned by institutional investors
Latest headline from investing.com: Sana Biotech stock target raised on clinical program updates

Sana Biotechnology Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Sana Stock often depends not only on the future outlook of the current and potential Sana Biotechnology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sana Biotechnology's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding194.5 M
Cash And Short Term Investments209 M

Sana Biotechnology Technical Analysis

Sana Biotechnology's future price can be derived by breaking down and analyzing its technical indicators over time. Sana Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Sana Biotechnology. In general, you should focus on analyzing Sana Stock price patterns and their correlations with different microeconomic environments and drivers.

Sana Biotechnology Predictive Forecast Models

Sana Biotechnology's time-series forecasting models is one of many Sana Biotechnology's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Sana Biotechnology's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Sana Biotechnology

Checking the ongoing alerts about Sana Biotechnology for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Sana Biotechnology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Sana Biotechnology is way too risky over 90 days horizon
Sana Biotechnology appears to be risky and price may revert if volatility continues
Net Loss for the year was (283.25 M) with profit before overhead, payroll, taxes, and interest of 0.
Sana Biotechnology currently holds about 484.8 M in cash with (253.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.57.
Sana Biotechnology has a frail financial position based on the latest SEC disclosures
Over 85.0% of the company shares are owned by institutional investors
Latest headline from investing.com: Sana Biotech stock target raised on clinical program updates
When determining whether Sana Biotechnology offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sana Biotechnology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sana Biotechnology Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sana Biotechnology Stock:

Complementary Tools for Sana Stock analysis

When running Sana Biotechnology's price analysis, check to measure Sana Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sana Biotechnology is operating at the current time. Most of Sana Biotechnology's value examination focuses on studying past and present price action to predict the probability of Sana Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sana Biotechnology's price. Additionally, you may evaluate how the addition of Sana Biotechnology to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Is Sana Biotechnology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sana Biotechnology. If investors know Sana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sana Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.46)
Return On Assets
(0.29)
Return On Equity
(0.72)
The market value of Sana Biotechnology is measured differently than its book value, which is the value of Sana that is recorded on the company's balance sheet. Investors also form their own opinion of Sana Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Sana Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sana Biotechnology's market value can be influenced by many factors that don't directly affect Sana Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sana Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sana Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sana Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.